Literature DB >> 203726

Laetrile toxicity studies in dogs.

E S Schmidt, G W Newton, S M Sanders, J P Lewis, E E Conn.   

Abstract

Dogs were fed laetrile and fresh, sweet almonds under various conditions. The doses of laetrile were similar to those prescribed for patients with cancer and ranged on a basis of gram to square meter from an equivalent of the oral dose for man to five times this dose. Six of the ten dogs died of cyanide poisoning. One dog recovered, and three dogs, at the time of sacrifice, demonstrated various levels of neurologic impairment, ranging from difficulty in walking to coma. These studies demonstrate that oral laetrile is highly toxic when taken with some common table foods. We predict that there will be an increased incidence of cyanide poisoning in man as laetrile becomes more readily available.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 203726

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

1.  Determination of amygdalin and its major metabolite prunasin in plasma and urine by high pressure liquid chromatography.

Authors:  A G Rauws; L G Gramberg; M Olling
Journal:  Pharm Weekbl Sci       Date:  1982-12-17

2.  Pharmacology of amygdalin (laetrile) in cancer patients.

Authors:  M M Ames; T P Moyer; J S Kovach; C G Moertel; J Rubin
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Amygdalin (Laetrile) and prunasin beta-glucosidases: distribution in germ-free rat and in human tumor tissue.

Authors:  J Newmark; R O Brady; P M Grimley; A E Gal; S G Waller; J R Thistlethwaite
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

4.  Amygdalin toxicity studies in rats predict chronic cyanide poisoning in humans.

Authors:  G W Newton; E S Schmidt; J P Lewis; E Conn; R Lawrence
Journal:  West J Med       Date:  1981-02

Review 5.  Laetrile for cancer: a systematic review of the clinical evidence.

Authors:  Stefania Milazzo; Stephane Lejeune; Edzard Ernst
Journal:  Support Care Cancer       Date:  2006-11-15       Impact factor: 3.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.